Rosenberg Abby R, Syrjala Karen L, Martin Paul J, Flowers Mary E, Carpenter Paul A, Salit Rachel B, Baker K Scott, Lee Stephanie J
Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington.
Department of Pediatrics, University of Washington, Seattle, Washington.
Cancer. 2015 Dec 1;121(23):4250-7. doi: 10.1002/cncr.29651. Epub 2015 Aug 19.
Low patient-reported resilience is associated with an ongoing risk of poor health and psychosocial outcomes. Using a large cross-sectional sample of survivors of hematopoietic cell transplantation (HCT), this study explored associations between patient-reported resilience, psychological distress, posttraumatic growth, and health-related quality of life.
Between July 1, 2013 and June 30, 2014, the annual Fred Hutchinson Cancer Research Center (FHCRC) posttransplant survivorship survey queried patient-reported health and functional status and included instruments assessing psychosocial outcomes: the 10-item Connor-Davidson Resilience Scale, the Posttraumatic Growth Inventory, the Cancer and Treatment Distress measure, and the 12-item Medical Outcomes Study Short Form quality-of-life scale. Multivariate linear and logistic regression models included demographic and health covariates extracted from the FHCRC research database.
Among 4643 adult survivors of HCT, 1823 (39%) responded after a single mailing and subsequent reminder letter. The participants' median age was 59 years (interquartile range [IQR], 50-66 years); 52.5% were male, and most were non-Hispanic white. The median time since HCT was 9 years (IQR, 3-18 years). Lower patient-reported resilience was associated with chronic graft-versus-host disease of higher severity, lower performance scores, missing work because of health, and permanent disability (all P < .0001). After adjustments for demographic and health characteristics, patients reporting low resilience scores had higher odds of having psychological distress (odds ratio [OR], 3.0; 95% confidence interval [CI], 2.1-4.3) and being in the lowest quartile for mental health-related quality of life (OR, 5.9; 95% CI, 4.4-8.0).
Patient-reported resilience is independently associated with health and psychosocial outcomes. Future studies must determine whether interventions can bolster resilience and improve survivorship outcomes.
患者报告的复原力较低与持续存在的健康状况不佳和心理社会不良后果风险相关。本研究使用造血细胞移植(HCT)幸存者的大型横断面样本,探讨了患者报告的复原力、心理困扰、创伤后成长和健康相关生活质量之间的关联。
在2013年7月1日至2014年6月30日期间,弗雷德·哈钦森癌症研究中心(FHCRC)年度移植后生存状况调查询问了患者报告的健康和功能状况,并纳入了评估心理社会后果的工具:10项Connor-Davidson复原力量表、创伤后成长量表、癌症与治疗困扰量表以及12项医学结果研究简表生活质量量表。多变量线性和逻辑回归模型纳入了从FHCRC研究数据库中提取的人口统计学和健康协变量。
在4643名成年HCT幸存者中,1823人(39%)在收到一次邮件及后续提醒信后做出了回应。参与者的中位年龄为59岁(四分位间距[IQR],50 - 66岁);52.5%为男性,大多数是非西班牙裔白人。自HCT后的中位时间为9年(IQR,3 - 18年)。患者报告的较低复原力与更严重的慢性移植物抗宿主病、较低的表现评分、因健康原因缺勤以及永久性残疾相关(所有P < 0.0001)。在对人口统计学和健康特征进行调整后,报告复原力得分较低的患者出现心理困扰的几率更高(优势比[OR],3.0;95%置信区间[CI],2.1 - 4.3),并且心理健康相关生活质量处于最低四分位数的几率也更高(OR,5.9;95% CI,4.4 - 8.0)。
患者报告的复原力与健康和心理社会结果独立相关。未来的研究必须确定干预措施是否能够增强复原力并改善生存结果。